AMY LASH: Open Payments
NPI 1548640196 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 69 payments from 16 companies in 2025. Trend: 2023 $938 · 2024 $465 · 2025 $947
Food & beverage: $875Education: $72
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 34 | $237 |
| Janssen Biotech, Inc. | 6 | $157 |
| Novartis Pharmaceuticals Corporation | 6 | $137 |
| GENZYME CORPORATION | 4 | $70 |
| LEO Pharma Inc. | 3 | $68 |
| ABBVIE INC. | 4 | $66 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Amgen Inc. | 1 | $27 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $20 |
Products named: Bimzelx, TREMFYA, DUPIXENT, Sotyktu, SKYRIZI, ANZUPGO, ADBRY, Rhapsido.
Industry payments across FL — which companies pay providers there.
